Efficacy of restaining prostate needle biopsies with high-molecular weight cytokeratin

被引:14
作者
Dardik, M
Epstein, JI
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA
关键词
prostate carcinoma; high molecular weight cytokeratin; immunohistochemistry;
D O I
10.1053/hupa.2000.17989
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Prostate tissue and lesions obtained by needle biopsy may be scant and not survive cutting into the block; this study examined the efficacy of destaining hematoxylin and eosin-stained sections and restaining the slides using immunohistochemistry with high-molecular weight cytokeratin (high-molecular weight cytokeratin). We identified 105 prostate needle biopsies referred to Johns Hopkins Hospital in an 18-month period (January 1997-June 1998) that had been destained and restained for high molecular weight cytokeratin, The slides,were reviewed for the Johns Hopkins Hospital diagnosis (benign, malignant, or equivocal), which had factored in the immunohistochemistry results, and for immunohistochemistry staining quality (optimal, suboptimal, stain failed, or lesion fell off), We obtained data on 96 cases from the referring institutions about the fixative and glass slides used for processing the needle biopsy, In 58% of cases, destaining and restaining with high-molecular weight cytokeratin allowed a definitive benign or malignant diagnosis to be made; in 79% of these cases, the staining was optimal. In only 13% of cases the diagnosis remained equivocal; of these, the stain worked optimally in only 36%. In 19% of cases, the stain failed. In 9% of cases, the lesion fell off; in all 7 cases with available data the tissue had been cut on non-charged slides. All but 3 cases were received in 10% neutral buffered formalin. There was no correlation between the use of charged (plus or lysine coated) or non-charged slides and the staining quality. Furthermore, in 12 instances, we received more than 1 specimen from the same referring institution, and in 6 of these instances there was variable staining in the different cases from the same institution, Destaining hematoxylin and eosin-stained slides and restaining for high-molecular weight cytokeratin is a useful technique that in the majority of cases enables a definitive diagnosis to be made. Tissue may survive the procedure better if originally cut on charged slides, but staining quality is no different for charged or non-charged slides, Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:1155 / 1161
页数:7
相关论文
共 16 条
[1]  
Goldstein NS, 1999, AM J CLIN PATHOL, V112, P69
[2]   Anticytokeratin antibody 34 beta E12 staining in prostate carcinoma [J].
Googe, PB ;
McGinley, KM ;
Fitzgibbon, JF .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (02) :219-223
[3]  
GOWN AM, 1984, AM J PATHOL, V114, P309
[4]   Use of intervening unstained slides for immunohistochemical stains for high molecular weight cytokeratin on prostate needle biopsies [J].
Green, R ;
Epstein, JI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (05) :567-570
[5]   USE OF KERATIN 903 AS AN ADJUNCT IN THE DIAGNOSIS OF PROSTATE CARCINOMA [J].
HEDRICK, L ;
EPSTEIN, JI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1989, 13 (05) :389-396
[6]   UTILIZATION OF HIGH-MOLECULAR-WEIGHT CYTOKERATIN ON PROSTATE NEEDLE BIOPSIES IN AN INDEPENDENT LABORATORY [J].
KAHANE, H ;
SHARP, JW ;
SHUMAN, GB ;
DASILVA, G ;
EPSTEIN, JI .
UROLOGY, 1995, 45 (06) :981-986
[7]  
NAGLE RB, 1987, CANCER RES, V47, P281
[8]   KERATIN PROFILES IN NORMAL HYPERPLASTIC PROSTATES AND PROSTATE CARCINOMA [J].
OKADA, H ;
TSUBURA, A ;
OKAMURA, A ;
SENZAKI, H ;
NAKA, Y ;
KOMATZ, Y ;
MORII, S .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 421 (02) :157-161
[9]   USEFULNESS OF IMMUNOPEROXIDASE STAINING WITH HIGH-MOLECULAR-WEIGHT CYTOKERATIN IN THE DIFFERENTIAL-DIAGNOSIS OF SMALL-ACINAR LESIONS OF THE PROSTATE-GLAND [J].
OMALLEY, FP ;
GRIGNON, DJ ;
SHUM, DT .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1990, 417 (03) :191-196
[10]  
SCHLEGEL R, 1980, LAB INVEST, V42, P91